Mirae Asset Global Investments Co., Ltd. Biotechnology

Mirae Asset Global Investments Co., Ltd.

$28 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
EYPT Eye Point Pharmaceuticals, Inc.	$455M	$25,000 0.0% of portfolio	2,658	Q2 2025 Added 18.08%
PHAT Phathom Pharmaceuticals, Inc.	$464M	$25,000 0.0% of portfolio	2,697	Q2 2025 Added 17.88%
URGN Uro Gen Pharma Ltd.	$437M	$24,000 0.0% of portfolio	1,781	Q2 2025 Added 22.32%
SANA Sana Biotechnology, Inc.	$613M	$23,000 0.0% of portfolio	8,713	Q2 2025 Added 16.62%
STOK Stoke Therapeutics, Inc.	$925M	$23,000 0.0% of portfolio	2,109	Q2 2025 Added 18.02%
TSHA Taysha Gene Therapies, Inc.	$148M	$23,000 0.0% of portfolio	10,103	Q2 2025 Added 58.55%
AMLX Amylyx Pharmaceuticals, Inc.	$693M	$22,000 0.0% of portfolio	3,443	Q2 2025 Added 17.51%
ABUS Arbutus Biopharma Corp	$669M	$22,000 0.0% of portfolio	7,399	Q2 2025 Added 16.69%
IOVA Iovance Biotherapeutics, Inc.	$358M	$22,000 0.0% of portfolio	12,900	Q2 2025 Added 17.58%
RLAY Relay Therapeutics, Inc.	$480M	$22,000 0.0% of portfolio	6,623	Q2 2025 Added 19.98%
SAGE Sage Therapeutics, Inc.	$516M	$22,000 0.0% of portfolio	2,419	Q2 2025 Added 17.6%
KALV Kal Vista Pharmaceuticals, Inc.	$345M	$21,000 0.0% of portfolio	1,921	Q2 2025 Added 17.13%
TNGX Tango Therapeutics, Inc.	$575M	$21,000 0.0% of portfolio	4,187	Q2 2025 Added 12.16%
TBPH Theravance Biopharma, Inc.	$955M	$21,000 0.0% of portfolio	1,932	Q2 2025 Added 17.45%
TRVI Trevi Therapeutics, Inc.	$481M	$21,000 0.0% of portfolio	3,930	Q2 2025 Added 35.42%
XNCR Xencor Inc	$513M	$21,000 0.0% of portfolio	2,749	Q2 2025 Added 16.58%
ARVN Arvinas, Inc.	$412M	$20,000 0.0% of portfolio	2,820	Q2 2025 Added 22.56%
KROS Keros Therapeutics, Inc.	$403M	$20,000 0.0% of portfolio	1,569	Q2 2025 Added 15.37%
MGTX Meira G Tx Holdings PLC	$343M	$20,000 0.0% of portfolio	3,104	Q2 2025 Added 18.7%
KURA Kura Oncology, Inc.	$548M	$19,000 0.0% of portfolio	3,344	Q2 2025 Added 23.76%
TYRA Tyra Biosciences, Inc.	$526M	$19,000 0.0% of portfolio	2,054	Q2 2025 Added 21.32%
AUTL Autolus Therapeutics PLC	$125M	$17,000 0.0% of portfolio	7,746	Q2 2025 Added 33.78%
CGEM Cullinan Oncology, Inc.	$298M	$17,000 0.0% of portfolio	2,280	Q2 2025 Added 15.5%
GLPG Galapagos Nv	$2.11B	$16,000 0.0% of portfolio	572	Q2 2025 Added 16.97%
PGEN Precigen, Inc.	$789M	$16,000 0.0% of portfolio	11,403	Q2 2025 Added 16.36%
RGNX Regenxbio Inc.	$398M	$15,000 0.0% of portfolio	1,938	Q2 2025 Added 18.82%
SVRA Savara Inc	$401M	$15,000 0.0% of portfolio	6,677	Q2 2025 Added 16.26%
AURA Aura Biosciences, Inc.	$181M	$14,000 0.0% of portfolio	2,395	Q2 2025 Added 44.63%
ITOS I Teos Therapeutics, Inc.	$361M	$14,000 0.0% of portfolio	1,479	Q2 2025 Added 21.03%
ARCT Arcturus Therapeutics Holdings Inc.	$460M	$13,000 0.0% of portfolio	1,048	Q2 2025 Added 15.67%
ERAS Erasca, Inc.	$191M	$13,000 0.0% of portfolio	10,943	Q2 2025 Added 15.68%
LXRX Lexicon Pharmaceuticals, Inc.	$217M	$13,000 0.0% of portfolio	14,029	Q2 2025 Added 15.98%
MRVI Maravai Lifesciences Holdings, Inc.	$351M	$13,000 0.0% of portfolio	5,562	Q2 2025 Added 18.64%
ABSI Absci Corp	$237M	$12,000 0.0% of portfolio	4,928	Q2 2025 Added 28.23%
ALT Altimmune, Inc.	$178M	$12,000 0.0% of portfolio	3,133	Q2 2025 Added 21.58%
HUMA Humacyte, Inc.	$151M	$12,000 0.0% of portfolio	5,992	Q2 2025 Added 44.87%
PRTA Prothena Corp Public LTD CO	$385M	$12,000 0.0% of portfolio	2,079	Q2 2025 Added 15.44%
TERN Terns Pharmaceuticals, Inc.	$272M	$12,000 0.0% of portfolio	3,374	Q2 2025 Added 18.72%
ATXS Astria Therapeutics, Inc.	$113M	$11,000 0.0% of portfolio	2,180	Q2 2025 Added 14.38%
AVIR Atea Pharmaceuticals, Inc.	$261M	$11,000 0.0% of portfolio	3,306	Q2 2025 Added 16.99%
BCYC Bicycle Therapeutics PLC	$210M	$11,000 0.0% of portfolio	1,705	Q2 2025 Added 16.46%
CRVS Corvus Pharmaceuticals, Inc.	$271M	$11,000 0.0% of portfolio	2,979	Q2 2025 Added 45.46%
OLMA Olema Pharmaceuticals, Inc.	$314M	$11,000 0.0% of portfolio	2,643	Q2 2025 Added 6.4%
ANNX Annexon, Inc.	$115M	$10,000 0.0% of portfolio	4,238	Q2 2025 Added 18.81%
ELYM Eliem Therapeutics, Inc.	$109M	$10,000 0.0% of portfolio	2,610	Q2 2025 Added 16.05%
FHTX Foghorn Therapeutics Inc.	$216M	$10,000 0.0% of portfolio	2,153	Q2 2025 Added 15.69%
GLUE Monte Rosa Therapeutics, Inc.	$225M	$10,000 0.0% of portfolio	2,376	Q2 2025 Added 15.56%
RCKT Rocket Pharmaceuticals, Inc.	$239M	$10,000 0.0% of portfolio	4,162	Q2 2025 Added 16.65%
SLN Silence Therapeutics PLC	$162M	$10,000 0.0% of portfolio	1,817	Q2 2025 Added 15.51%
VNDA Vanda Pharmaceuticals Inc.	$255M	$10,000 0.0% of portfolio	2,277	Q2 2025 Added 16.71%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.